• Patients
  • Careers
  • Contact
Frequency Therapeutics
  • About

    About

    We are a clinical-stage biotechnology company focused on restoring function by developing therapeutics that activate a person’s innate regenerative potential.

    • About Us
    • Leadership
    • Board of Directors
    • PCA Regenerative Medicine Advisory Board
    • Hearing Clinical Advisory Board
    • Remyelination Advisory Board
  • Our Science

    Our Science

    Frequency is leading a new category in regenerative medicine designed to activate a person’s innate regenerative potential, within the body, to repair tissue and restore function.

    • PCA Approach
    • Therapeutic Discovery Process
    • Publications
  • Pipeline & Programs

    Pipeline & Programs

    Developing small-molecule treatments to reverse the debilitating impact of degenerative diseases

    • Pipeline
    • Hearing Program
    • Multiple Sclerosis Program
    • Strategic Partnerships
  • Hearing Loss

    Hearing Loss

    Hearing loss caused by damage to the sensory cells of the ear impacts hundreds of millions of people globally. Currently there are no FDA-approved treatments to address the underlying condition.

    • About Hearing Loss
    • How We Hear
    • Sensorineural Hearing Loss
    • Sound Clarity and Speech Perception
    • Hearing Loss: A Growing Public Health Problem
  • Investors & Media

    Investors & Media

    • Overview
    • Corporate Governance
    • Press Releases
    • Events & Presentations
    • Stock Information
    • SEC Filings
    • Investor FAQ
    • Investor & Media Contacts
  • About
    • About Us
    • Leadership
    • Board of Directors
    • PCA Regenerative Medicine Advisory Board
    • Hearing Clinical Advisory Board
    • Remyelination Advisory Board
  • Our Science
    • PCA Approach
    • Therapeutic Discovery Process
    • Publications
  • Pipeline & Programs
    • Pipeline
    • Hearing Program
    • Multiple Sclerosis Program
    • Strategic Partnerships
  • Hearing Loss
    • About Hearing Loss
    • How We Hear
    • Sensorineural Hearing Loss
    • Sound Clarity and Speech Perception
    • Hearing Loss: A Growing Public Health Problem
  • Investors & Media
    • Overview
    • Corporate Governance
    • Press Releases
    • Events & Presentations
    • Stock Information
    • SEC Filings
    • Investor FAQ
    • Investor & Media Contacts
  • Patients
  • Careers
  • Contact Us

Board of Directors

Read Bio

Marc A. Cohen

Chairman, In Memoriam

Read Bio

David Lucchino

Co-founder, President and CEO

Read Bio

Tim Barberich

Vice Chairman

Read Bio

Cynthia L. Feldmann

Independent Board Member

Read Bio

Michael Huang

Managing Partner, Taiwania Capital Management

Read Bio

Robert S. Langer, ScD

Institute Professor, Massachusetts Institute of Technology

Read Bio

Joel S. Marcus, CPA, JD

Executive Chairman and Founder, Alexandria Real Estate Equities, Inc.

Interested in joining our team? Explore careers

© 2023 Frequency Therapeutics
  • Open Positions
  • Contact
  • Privacy Policy
  • Terms & Conditions